Reviva Pharmaceuticals Holdings, Inc. (RVPH) — DEF 14A Filings
All DEF 14A filings from Reviva Pharmaceuticals Holdings, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Reviva Pharma Seeks Share Increase, Reverse Split Ahead of Key Vote
— Nov 4, 2025 Risk: high
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) is holding its Annual Meeting on December 18, 2025, where stockholders will vote on several critical proposals. Key -
Reviva Pharmaceuticals Holdings DEF 14A Filing
— Oct 28, 2024 Risk: low
Reviva Pharmaceuticals Holdings, Inc. filed a definitive proxy statement (DEF 14A) on October 28, 2024, for its annual meeting on December 10, 2024. The company
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX